Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Cel Sci Corporation New CVM

Healthcare Biotechnology
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company’s lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation... see more

Current News (NYSEAM:CVM)

CEL-SCI Reports Fiscal 2025 Results

Business Wire December 29, 2025

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

Newsfile October 20, 2025

CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference

Newsfile October 10, 2025

CEL-SCI Announces Closing of $10 Million Public Offering

Business Wire August 29, 2025

CEL-SCI Announces Pricing of $10 Million Public Offering

Business Wire August 27, 2025

CEL-SCI Announces Proposed Public Offering

Business Wire August 27, 2025

CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results

Business Wire August 14, 2025

CEL-SCI's Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline

Business Wire August 13, 2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

Business Wire July 14, 2025
View More News ››

Opinion & Analysis (NYSEAM:CVM)

Alternative, green energy stock picks

J.W. Cotton December 2, 2009

Stock picks with insider buying

J.W. Cotton November 20, 2008

Dividend and speculative stock picks

J.W. Cotton October 28, 2008
View More Opinion ››

Bullboard Posts (NYSEAM:CVM)

$CVM Huge

VIENNA, Va., July 14, 2025--(BUSINESS WIRE)--CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE American: CVM),...
stock2watch1 - July 18, 2025

$CVM looking to bounce ?

...............
stock2watch1 - July 16, 2025

RE:CVM ....Green to Red move imminent

Worth a repeat.....low of $3.41 You've all been had
Iseneschal - July 11, 2025

CVM ....Green to Red move imminent

Total escrement
Iseneschal - July 11, 2025

CVM...It's back trading....LoL

Now at $4.00
Iseneschal - July 11, 2025

CVM....yes it is Halted

Well now u know why I try to be as agile as possible. This is a perfect example of how there is always a " Curveball " thrown...
Iseneschal - July 11, 2025
View more Bullboard ››

Mullen Group Ltd

Mullen Group Ltd

Mullen Group Ltd. provides a range of trucking and logistics services in Canada and the United States. It operates through ...
View More »

Podcasts